Maternal influenza vaccine reduces the risk of RSV and related respiratory hospitalisations in early infancy: an epidemiological study | Synapse
February 27, 2026
Maternal influenza vaccine reduces the risk of RSV and related respiratory hospitalisations in early infancy: an epidemiological study
Key Points
The study aims to evaluate the impact of maternal influenza vaccination on the risk of RSV-related hospitalisations in infancy.
Epidemiological study design
Analysis of hospitalisation data
Assessment of maternal influenza vaccination rates
Review of respiratory illness cases
Maternal vaccination is associated with a reduction in RSV hospitalisations in early infancy.
Findings emphasize the importance of maternal immunisation for improving infant health outcomes.
Abstract
Non-specific effects should be included in the full public health evaluation of maternal IIV. These findings are important for policymakers and community to improve immunisation.